India's active cases cases dipped to 20,403.
Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
The active cases comprise 0.05 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 98.74 per cent, the ministry said.
The case fatality rate has dropped 2.01 per cent, according to ministry data.
The COVID-19 case fatality rate due to the coronavirus infection has further dropped to 1.66 per cent.
A nasal vaccine, one expert said, is a "fantastic idea" for two reasons -- one, it can potentially create sterile immunity, and two, it is easy to administer and thus scalable.
The decline in the effectiveness of Covaxin, India's indigenous COVID-19 vaccine, from 77.8 per cent to 50 per cent during a Delta-driven case surge in April and May this year is neither bad nor surprising, say scientists.
After identifying the man who was the patient zero or index case of the Nipah virus outbreak in Kerala, the state government on Saturday began looking for the source and place from where he got infected by seeking details of his mobile tower locations.
There are 8,15,538 active cases of coronavirus infection in the country.
The death toll has climbed to 5,26,312 with 44 new fatalities, the data updated by the government at 8 am said.
While Maharashtra Home Minister Anil Deshmukh warned the yoga guru that the state government won't allow the sale of 'spurious' medicines, Rajasthan Health Minister Raghu Sharma also said that the state government will not allow the sale of Patanjali's Ayurvedic formulation.
India logged 3,377 new COVID-19 infections taking the country's total tally of cases to 4,30,72,176, while the active cases rose to 17,801, according to the Union health ministry data updated on Friday.
The total active cases increased by 643 in a day and comprised 0.04 per cent of the total infections.
COVID-19 cases in the country jumped from 10 lakh to 20 lakh in 21 days, while it had taken 59 days for the cases to cross the 10 lakh-mark.
The COVID-19 case fatality rate stands at 1.48 per cent.
India's COVID-19 tally climbed to 4,38,68,476 on Saturday with 21,411 fresh cases, while the number of active cases increased to 1,50,100, according to Union health ministry data.
According to the Indian Council of Medical Research, a cumulative total of 11,85,72,192 samples have been tested up to November 8 with 8,35,401 test being conducted on Sunday.
Maharashtra Health Minister Rajesh Tope said the lowering of rates for the tests would provide a relief to the people.
An increase of 1,093 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.
The death toll climbed to 5,21,965 with 214 fresh fatalities, including 213 from Kerala.
India's COVID-19 tally climbed to 4,30,40,947 on Saturday with 975 more people testing positive for the viral disease, while the active cases increased to 11,366, according to Union health ministry data.
In the trial, the vaccine will be given by the intramuscular route in two doses on day 0 and day 28.
The active Covid cases have increased to 1,32,457. They comprise 0.30 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 98.49 per cent, the ministry said.
The active cases comprise 0.03 per cent of the total infections, while the national COVID-19 recovery rate remained at 98.76 per cent, the ministry said.
The active cases comprise 0.03 per cent of the total infections, while the national COVID-19 recovery rate remained at 98.76 per cent, the ministry said.
The active cases comprise 0.30 per cent of the total infections.
The active cases account for 0.03 per cent of the total caseload, while the national COVID-19 recovery rate remained at 98.76 per cent, the ministry said.
The national Covid recovery rate was recorded at 98.10 per cent, the data updated at 8 am showed.
The death toll has climbed to 5,25,343 with 38 new fatalities, the data updated at 8 am showed.
The active cases comprise 0.03 per cent of the total infections, while the national COVID-19 recovery rate remained at 98.76 per cent, the ministry said.
Responding to a question over an Indian Council of Medical Research study which stated that 40 out of 104 people having severe acute respiratory infection and later tested positive for coronavirus did not have any recent international travel history or contact with any confirmed cases of the disease, senior official of the ministry Lav Agarwal asserted, "No community transmission has happened in the country so far. There is no need to panic."
'We condemn recent illicit missile launches in the region that violate UN Security Council resolutions. We express serious concern over recent dangerous and aggressive actions in the maritime domain. We seek a region where no country dominates and no country is dominated one where all countries are free from coercion, and can exercise their agency to determine their futures,' the declaration said.
The total number of samples tested up to August 19 is 3,26,61,252 including 9,18,470 samples tested on Wednesday, said the Indian Council of Medical Research on Thursday.
Active cases of infection fell below 9 lakh after a month comprising 12.94 per cent of the total caseload
India recorded COVID-19 cases below 1,000 for the first time since April 18, 2020 when 991 cases were reported.
The active cases comprise 0.03 per cent of the total infections.
A reduction of 635 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.
The death toll climbed to 5,25,199 with 31 new fatalities, the data updated at 8 am stated.
The government has ordered monoclonal antibody from Indian Council of Medical Research to treat the child. It is the only available anti-viral treatment for Nipah virus infection, though it has not been clinically proven yet.
Vardhan said the ICMR is actively researching on reports of COVID-19 reinfection and although the number of such cases is negligible at this moment, the government is fully seized of the importance of the matter, the health ministry said in a statement.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances